About TRIDEM Pharma
TRIDEM Pharma is a company based in Escalquens (France) founded in 1986 by Gerard Bayle was acquired by Fosun in October 2017. TRIDEM Pharma offers products and services including Pharmaceutical Outsourcing and Tailor-Made Business Solutions. TRIDEM Pharma operates in a competitive market with competitors including AmerisourceBergen, EUROTRANSPHARMA, PIEX, Nutravalia and e-THEMIS, among others.
- Headquarter Escalquens, France
- Founders Gerard Bayle
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tridem Pharma
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TRIDEM Pharma
TRIDEM Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Outsourcing and Tailor-Made Business Solutions.
One-stop service for bringing healthcare products to African markets
Custom solutions to expand pharmaceutical activities in Africa
Funding Insights of TRIDEM Pharma
Detailed funding history for TRIDEM Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in TRIDEM Pharma
TRIDEM Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fosun.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment, asset management, and insurance services are offered globally.
|
Locked | Locked | Locked |
Investor details for TRIDEM Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TRIDEM Pharma
Investment portfolio details for TRIDEM Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TRIDEM Pharma
Detailed financials for TRIDEM Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tridem Pharma Comparisons
Peer comparison for TRIDEM Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TRIDEM Pharma
TRIDEM Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, EUROTRANSPHARMA, PIEX, Nutravalia and e-THEMIS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Offers secure pharmaceutical distribution and last mile logistics services across Europe.
|
|
| Locked | Locked | Locked |
Diversified drugs are supplied by PIEX from Paris operations.
|
|
| Locked | Locked | Locked |
Manufacturer and distributor of food supplements, cosmetics, pharmaceutical, herbal teas, and derived products
|
|
| Locked | Locked | Locked |
Diversified drugs are distributed by e-THEMIS in pharmaceutical markets.
|
Detailed competitors of TRIDEM Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tridem Pharma
Complete news archive for TRIDEM Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TRIDEM Pharma
TRIDEM Pharma was founded in 1986.
TRIDEM Pharma is headquartered in Escalquens, France. It is registered at Escalquens, Haute-garonne, France.
Annual revenue of TRIDEM Pharma is $213.67M as on Dec 31, 2023.
TRIDEM Pharma was established in 1986 by Gerard Bayle in Escalquens, France. Distribution of pharmaceutical products is handled within the healthcare sector. Operations encompass supply chain logistics for medicines, including procurement and delivery to wholesalers and retailers. Services are provided across European markets, with a focus on regulatory compliance and efficient inventory management. The domain tridem-pharma.com supports online inquiries and partnerships.
TRIDEM Pharma's top competitors include AmerisourceBergen, PIEX and e-THEMIS.
TRIDEM Pharma offers Pharmaceutical Outsourcing and Tailor-Made Business Solutions.
TRIDEM Pharma has 1 investor. Key investors include Fosun.